Author:
Buyck J. M.,Luyckx C.,Muccioli G. G.,Krause K. M.,Nichols W. W.,Tulkens P. M.,Van Bambeke F.
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Reference41 articles.
1. Mechanisms of antimicrobial resistance in Gram-negative bacilli;Ruppé;Ann Intensive Care,2015
2. In vitro models for the study of the intracellular activity of antibiotics;Buyck;Methods Mol Biol,2016
3. In vitro activity of AVE1330A, an innovative broad-spectrum non- -lactam -lactamase inhibitor
4. Robbins MJ Cassettari M Dencer C . In vitro activity of NXL104 (NXL), a new β-lactamase inhibitor, in combination with cefpodoxime (CPD) and cefixime (CFM) against 3rd generation cephalosporin-resistant isolates of species of the Enterobacteriaceae. In: Abstracts of the Forty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 2005. Abstract F-1161, p. 187. American Society for Microbiology, Washington, DC, USA.
5. NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum -lactamases and carbapenemases
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献